跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dulostal-60 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Dulostal-60
Approved
STANDARD
Dulostal-60
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9f11635a5e985bd9
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
9f11635a5e985bd9
Drug Approval Philippines Name
Dulostal-60
Product Name
Dulostal-60
Registration Number
DRP-13483
Brand Name
Dulostal-60
Generic Name
Duloxetine (as Hydrochloride)
Dosage Form
Delayed Release Capsule
Dosage Strength
60 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
27 February 2023
Expiry Date
27 February 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9f11635a5e985bd9
Type
Standard
Back to Philippines FDA Approvals